467 related articles for article (PubMed ID: 34757660)
1. Integrative metabolomics-genomics approach reveals key metabolic pathways and regulators of Alzheimer's disease.
Horgusluoglu E; Neff R; Song WM; Wang M; Wang Q; Arnold M; Krumsiek J; Galindo-Prieto B; Ming C; Nho K; Kastenmüller G; Han X; Baillie R; Zeng Q; Andrews S; Cheng H; Hao K; Goate A; Bennett DA; Saykin AJ; Kaddurah-Daouk R; Zhang B; ;
Alzheimers Dement; 2022 Jun; 18(6):1260-1278. PubMed ID: 34757660
[TBL] [Abstract][Full Text] [Related]
2. Dysregulation of multiple metabolic networks related to brain transmethylation and polyamine pathways in Alzheimer disease: A targeted metabolomic and transcriptomic study.
Mahajan UV; Varma VR; Griswold ME; Blackshear CT; An Y; Oommen AM; Varma S; Troncoso JC; Pletnikova O; O'Brien R; Hohman TJ; Legido-Quigley C; Thambisetty M
PLoS Med; 2020 Jan; 17(1):e1003012. PubMed ID: 31978055
[TBL] [Abstract][Full Text] [Related]
3. Brain and blood metabolite signatures of pathology and progression in Alzheimer disease: A targeted metabolomics study.
Varma VR; Oommen AM; Varma S; Casanova R; An Y; Andrews RM; O'Brien R; Pletnikova O; Troncoso JC; Toledo J; Baillie R; Arnold M; Kastenmueller G; Nho K; Doraiswamy PM; Saykin AJ; Kaddurah-Daouk R; Legido-Quigley C; Thambisetty M
PLoS Med; 2018 Jan; 15(1):e1002482. PubMed ID: 29370177
[TBL] [Abstract][Full Text] [Related]
4. Integrative metabolomics science in Alzheimer's disease: Relevance and future perspectives.
Lista S; González-Domínguez R; López-Ortiz S; González-Domínguez Á; Menéndez H; Martín-Hernández J; Lucia A; Emanuele E; Centonze D; Imbimbo BP; Triaca V; Lionetto L; Simmaco M; Cuperlovic-Culf M; Mill J; Li L; Mapstone M; Santos-Lozano A; Nisticò R
Ageing Res Rev; 2023 Aug; 89():101987. PubMed ID: 37343679
[TBL] [Abstract][Full Text] [Related]
5. Integrated analysis of genomics, longitudinal metabolomics, and Alzheimer's risk factors among 1,111 cohort participants.
Darst BF; Lu Q; Johnson SC; Engelman CD
Genet Epidemiol; 2019 Sep; 43(6):657-674. PubMed ID: 31104335
[TBL] [Abstract][Full Text] [Related]
6. Multiomics analysis to explore blood metabolite biomarkers in an Alzheimer's Disease Neuroimaging Initiative cohort.
Oka T; Matsuzawa Y; Tsuneyoshi M; Nakamura Y; Aoshima K; Tsugawa H;
Sci Rep; 2024 Apr; 14(1):6797. PubMed ID: 38565541
[TBL] [Abstract][Full Text] [Related]
7. Sex specific molecular networks and key drivers of Alzheimer's disease.
Guo L; Cao J; Hou J; Li Y; Huang M; Zhu L; Zhang L; Lee Y; Duarte ML; Zhou X; Wang M; Liu CC; Martens Y; Chao M; Goate A; Bu G; Haroutunian V; Cai D; Zhang B
Mol Neurodegener; 2023 Jun; 18(1):39. PubMed ID: 37340466
[TBL] [Abstract][Full Text] [Related]
8. Molecular insights into sex-specific metabolic alterations in Alzheimer's mouse brain using multi-omics approach.
Strefeler A; Jan M; Quadroni M; Teav T; Rosenberg N; Chatton JY; Guex N; Gallart-Ayala H; Ivanisevic J
Alzheimers Res Ther; 2023 Jan; 15(1):8. PubMed ID: 36624525
[TBL] [Abstract][Full Text] [Related]
9. Characterizing Alzheimer's disease through metabolomics and investigating anti-Alzheimer's disease effects of natural products.
Yi L; Liu W; Wang Z; Ren D; Peng W
Ann N Y Acad Sci; 2017 Jun; 1398(1):130-141. PubMed ID: 28632966
[TBL] [Abstract][Full Text] [Related]
10. An integrated brain-specific network identifies genes associated with neuropathologic and clinical traits of Alzheimer's disease.
Lin CX; Li HD; Deng C; Liu W; Erhardt S; Wu FX; Zhao XM; Guan Y; Wang J; Wang D; Hu B; Wang J
Brief Bioinform; 2022 Jan; 23(1):. PubMed ID: 34953465
[TBL] [Abstract][Full Text] [Related]
11. Integrative network analysis of nineteen brain regions identifies molecular signatures and networks underlying selective regional vulnerability to Alzheimer's disease.
Wang M; Roussos P; McKenzie A; Zhou X; Kajiwara Y; Brennand KJ; De Luca GC; Crary JF; Casaccia P; Buxbaum JD; Ehrlich M; Gandy S; Goate A; Katsel P; Schadt E; Haroutunian V; Zhang B
Genome Med; 2016 Nov; 8(1):104. PubMed ID: 27799057
[TBL] [Abstract][Full Text] [Related]
12. Brain and blood metabolome for Alzheimer's dementia: findings from a targeted metabolomics analysis.
Huo Z; Yu L; Yang J; Zhu Y; Bennett DA; Zhao J
Neurobiol Aging; 2020 Feb; 86():123-133. PubMed ID: 31785839
[TBL] [Abstract][Full Text] [Related]
13. Bile acid synthesis, modulation, and dementia: A metabolomic, transcriptomic, and pharmacoepidemiologic study.
Varma VR; Wang Y; An Y; Varma S; Bilgel M; Doshi J; Legido-Quigley C; Delgado JC; Oommen AM; Roberts JA; Wong DF; Davatzikos C; Resnick SM; Troncoso JC; Pletnikova O; O'Brien R; Hak E; Baak BN; Pfeiffer R; Baloni P; Mohmoudiandehkordi S; Nho K; Kaddurah-Daouk R; Bennett DA; Gadalla SM; Thambisetty M
PLoS Med; 2021 May; 18(5):e1003615. PubMed ID: 34043628
[TBL] [Abstract][Full Text] [Related]
14. Comparative Metabolomics Analysis Reveals Key Metabolic Mechanisms and Protein Biomarkers in Alzheimer's Disease.
Dai Z; Hu T; Su S; Liu J; Ma Y; Zhuo Y; Fang S; Wang Q; Mo Z; Pan H; Fang J
Front Pharmacol; 2022; 13():904857. PubMed ID: 35694256
[TBL] [Abstract][Full Text] [Related]
15. Analyzing the genes related to Alzheimer's disease via a network and pathway-based approach.
Hu YS; Xin J; Hu Y; Zhang L; Wang J
Alzheimers Res Ther; 2017 Apr; 9(1):29. PubMed ID: 28446202
[TBL] [Abstract][Full Text] [Related]
16. Understanding disease progression and improving Alzheimer's disease clinical trials: Recent highlights from the Alzheimer's Disease Neuroimaging Initiative.
Veitch DP; Weiner MW; Aisen PS; Beckett LA; Cairns NJ; Green RC; Harvey D; Jack CR; Jagust W; Morris JC; Petersen RC; Saykin AJ; Shaw LM; Toga AW; Trojanowski JQ;
Alzheimers Dement; 2019 Jan; 15(1):106-152. PubMed ID: 30321505
[TBL] [Abstract][Full Text] [Related]
17. Omics-based biomarkers discovery for Alzheimer's disease.
Aerqin Q; Wang ZT; Wu KM; He XY; Dong Q; Yu JT
Cell Mol Life Sci; 2022 Nov; 79(12):585. PubMed ID: 36348101
[TBL] [Abstract][Full Text] [Related]
18. Integrated network pharmacology analysis and serum metabolomics to reveal the cognitive improvement effect of Bushen Tiansui formula on Alzheimer's disease.
Zhang Z; Yi P; Yang J; Huang J; Xu P; Hu M; Zhang C; Wang B; Peng W
J Ethnopharmacol; 2020 Mar; 249():112371. PubMed ID: 31683034
[TBL] [Abstract][Full Text] [Related]
19. Multiscale network modeling of oligodendrocytes reveals molecular components of myelin dysregulation in Alzheimer's disease.
McKenzie AT; Moyon S; Wang M; Katsyv I; Song WM; Zhou X; Dammer EB; Duong DM; Aaker J; Zhao Y; Beckmann N; Wang P; Zhu J; Lah JJ; Seyfried NT; Levey AI; Katsel P; Haroutunian V; Schadt EE; Popko B; Casaccia P; Zhang B
Mol Neurodegener; 2017 Nov; 12(1):82. PubMed ID: 29110684
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
